Kar S, Vu K, Mottamal M, Al-Horani R
BMC Pharmacol Toxicol. 2022; 23(1):35.
PMID: 35642005
PMC: 9158266.
DOI: 10.1186/s40360-022-00575-5.
Lee S, Kang J, Ha J, Lee J, Oh S, Choi H
Int J Mol Sci. 2020; 21(14).
PMID: 32708896
PMC: 7404067.
DOI: 10.3390/ijms21145042.
Kang J, Lee S, Lee J, Oh S, Ha J, Choi H
Cells. 2020; 9(6).
PMID: 32560270
PMC: 7349864.
DOI: 10.3390/cells9061475.
Maglio M, Troncone R
Front Nutr. 2020; 7:73.
PMID: 32548124
PMC: 7273338.
DOI: 10.3389/fnut.2020.00073.
Al-Horani R, Kar S
Eur J Med Chem. 2020; 200:112442.
PMID: 32502864
PMC: 7513741.
DOI: 10.1016/j.ejmech.2020.112442.
Identification of Isopeptides Between Human Tissue Transglutaminase and Wheat, Rye, and Barley Gluten Peptides.
Lexhaller B, Ludwig C, Scherf K
Sci Rep. 2020; 10(1):7426.
PMID: 32367038
PMC: 7198585.
DOI: 10.1038/s41598-020-64143-9.
Proteolytic and nonproteolytic activation mechanisms result in conformationally and functionally different forms of coagulation factor XIII A.
Anokhin B, Dean W, Smith K, Flick M, Ariens R, Philippou H
FEBS J. 2019; 287(3):452-464.
PMID: 31407850
PMC: 7269131.
DOI: 10.1111/febs.15040.
Optimised methods (SDS/PAGE and LC-MS) reveal deamidation in all examined transglutaminase-mediated reactions.
Sivado E, El Alaoui M, Kiraly R, Fesus L, Delolme F, Page A
FEBS Open Bio. 2019; 9(2):396-404.
PMID: 30761263
PMC: 6356169.
DOI: 10.1002/2211-5463.12575.
Hispanic Spinocerebellar Ataxia Type 35 (SCA35) with a Novel Frameshift Mutation.
Lin C, Gan S, Gupta D, Alaedini A, Green P, Kuo S
Cerebellum. 2018; 18(2):291-294.
PMID: 30229425
PMC: 6544358.
DOI: 10.1007/s12311-018-0978-6.
The diamond anniversary of tissue transglutaminase: a protein of many talents.
Katt W, Antonyak M, Cerione R
Drug Discov Today. 2018; 23(3):575-591.
PMID: 29362136
PMC: 5864117.
DOI: 10.1016/j.drudis.2018.01.037.
Epitope-dependent Functional Effects of Celiac Disease Autoantibodies on Transglutaminase 2.
Hnida K, Stamnaes J, du Pre M, Mysling S, Jorgensen T, Sollid L
J Biol Chem. 2016; 291(49):25542-25552.
PMID: 27784785
PMC: 5207253.
DOI: 10.1074/jbc.M116.738161.
Dihydroisoxazole inhibitors of Anopheles gambiae seminal transglutaminase AgTG3.
Le B, Klock C, Schatz A, Nguyen J, Kakani E, Catteruccia F
Malar J. 2014; 13:210.
PMID: 24888439
PMC: 4113009.
DOI: 10.1186/1475-2875-13-210.
Injectable gel graft for bone defect repair.
Fang J, Yang Z, Tan S, Tayag C, Nimni M, Urata M
Regen Med. 2013; 9(1):41-51.
PMID: 24351005
PMC: 9302184.
DOI: 10.2217/rme.13.76.
Characterization of Anopheles gambiae transglutaminase 3 (AgTG3) and its native substrate Plugin.
Le B, Nguyen J, Logarajah S, Wang B, Marcus J, Williams H
J Biol Chem. 2013; 288(7):4844-53.
PMID: 23288850
PMC: 3576089.
DOI: 10.1074/jbc.M112.435347.
Transglutaminase inhibition: A therapy to protect cells from death in neurodegeneration?.
Iannaccone M, Stefanile A, De Vivo G, Martin A, Serretiello E, Gentile V
World J Biol Chem. 2012; 3(11):184-6.
PMID: 23193435
PMC: 3508428.
DOI: 10.4331/wjbc.v3.i11.184.
Celiac disease, inflammation and oxidative damage: a nutrigenetic approach.
Ferretti G, Bacchetti T, Masciangelo S, Saturni L
Nutrients. 2012; 4(4):243-57.
PMID: 22606367
PMC: 3347005.
DOI: 10.3390/nu4040243.
γ-Glutamylamines and neurodegenerative diseases.
Jeitner T, Battaile K, Cooper A
Amino Acids. 2012; 44(1):129-42.
PMID: 22407484
PMC: 3491119.
DOI: 10.1007/s00726-011-1209-3.
Detection of transglutaminase activity using click chemistry.
van Geel R, Debets M, Lowik D, Pruijn G, Boelens W
Amino Acids. 2011; 43(3):1251-63.
PMID: 22180026
PMC: 3418501.
DOI: 10.1007/s00726-011-1198-2.
Transglutaminase 2: a molecular Swiss army knife.
Gundemir S, Colak G, Tucholski J, Johnson G
Biochim Biophys Acta. 2011; 1823(2):406-19.
PMID: 22015769
PMC: 3265640.
DOI: 10.1016/j.bbamcr.2011.09.012.
Physio-pathological roles of transglutaminase-catalyzed reactions.
Ricotta M, Iannuzzi M, De Vivo G, Gentile V
World J Biol Chem. 2011; 1(5):181-7.
PMID: 21541002
PMC: 3083958.
DOI: 10.4331/wjbc.v1.i5.181.
